Qyuns Therapeutics Co., Ltd. (HKG:2509)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
19.38
+0.47 (2.49%)
At close: Mar 27, 2026

Qyuns Therapeutics Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
307.44-335.57-507.75-298.19-411.04
Depreciation & Amortization
-32.6732.2930.5425.64
Loss (Gain) From Sale of Assets
--0.01-0.01
Loss (Gain) From Sale of Investments
--4.24-5.7-11.9233.6
Stock-Based Compensation
-75.46131.341.5611.73
Other Operating Activities
92.4-2.47-0.8-14.08-2.09
Change in Accounts Receivable
--27.44-6.7--
Change in Inventory
--3.84-4.94--
Change in Accounts Payable
-78.5472.112.8117.38
Change in Unearned Revenue
-7.850.23-0.64-0.59
Change in Other Net Operating Assets
--7.06-10.7114.692.77
Operating Cash Flow
399.85-186.09-300.68-225.21-122.58
Capital Expenditures
--1.22-7.87-20.11-57.98
Sale (Purchase) of Intangibles
--0.54-0.07-2.65-0.96
Investment in Securities
--30.79246.3913.18-195.54
Other Investing Activities
118.697.334.673.887.06
Investing Cash Flow
118.69-25.23243.11-5.7-247.42
Long-Term Debt Issued
-512.33113.615.9-
Long-Term Debt Repaid
--338.73-66.65-16.55-3.01
Net Debt Issued (Repaid)
-173.6146.95-0.65-3.01
Issuance of Common Stock
-196.5429.5228300.07
Other Financing Activities
93.73-18.33-15.24-15.85-15.59
Financing Cash Flow
93.73351.8161.21211.49281.48
Foreign Exchange Rate Adjustments
-11.23.89-0.4314.46-2.72
Net Cash Flow
601.06144.393.21-4.97-91.23
Free Cash Flow
399.85-187.31-308.56-245.33-180.55
Free Cash Flow Margin
49.55%-117.96%--2539.08%-845.71%
Free Cash Flow Per Share
1.83-0.85-1.50-1.38-1.55
Cash Interest Paid
-17.5214.4215.4915.33
Levered Free Cash Flow
285.57-53.9-125.29-152.54-
Unlevered Free Cash Flow
299.42-39.28-114.78-140.86-
Change in Working Capital
-48.0649.9826.8619.56
Source: S&P Global Market Intelligence. Standard template. Financial Sources.